WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
CN Stock MarketDetailed Quotes
000972 Chalkis Health Industry
- 2.95
- -0.08-2.64%
Market Closed Apr 3 15:00 CST
2.28BMarket Cap-9.87P/E (TTM)
2.98High2.88Low271.77KlotVolume2.89Open3.03Pre Close79.61MTurnover3.52%Turnover RatioLossP/E (Static)771.28MShares4.0052wk High-81.94P/B2.28BFloat Cap2.1052wk Low3.18Limit Up771.28MShs Float18.81Historical High2.88Limit Down3.30%Amplitude1.49Historical Low--Dividend TTM2.93Avg Price144.93KlotAsk--Div YieldTTM100Lot Size109.91KlotBid
Chalkis Health Industry Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -46.48%308.15M | -13.19%297.82M | -14.86%245.13M | -20.49%119.25M | -2.29%575.78M | 122.52%343.06M | 184.84%287.92M | 502.51%149.99M | 237.79%589.29M | 1,994.85%154.17M |
| Operating revenue | -46.48%308.15M | -13.19%297.82M | -14.86%245.13M | -20.49%119.25M | -2.29%575.78M | 122.52%343.06M | 184.84%287.92M | 502.51%149.99M | 237.79%589.29M | 1,994.85%154.17M |
| Other operating revenue | -13.11%13.92M | ---- | 7.74%1.99M | ---- | 30.28%16.02M | ---- | 271.26%1.85M | ---- | 41.41%12.3M | ---- |
| Total operating cost | -26.86%377.82M | 6.23%311.48M | 0.95%240M | -15.52%113.7M | 6.53%516.56M | 79.63%293.23M | 108.90%237.74M | 347.99%134.59M | 121.34%484.89M | 198.63%163.24M |
| Operating cost | -31.94%292.8M | 4.61%256.22M | -2.07%202.7M | -17.31%97.09M | -0.99%430.21M | 77.50%244.94M | 123.33%206.98M | 515.89%117.41M | 164.07%434.53M | 1,652.71%138M |
| Operating tax surcharges | -14.64%5.37M | -40.07%2.19M | -14.09%2.07M | -71.06%88.35K | 52.68%6.3M | 140.46%3.65M | 93.15%2.41M | 162.25%305.27K | 30.81%4.12M | 23.34%1.52M |
| Operating expense | -30.44%7.88M | 79.26%6.5M | 126.70%3.5M | 5.39%1.44M | 98.49%11.33M | 843.44%3.63M | 436.04%1.55M | 874.70%1.37M | 5,852.57%5.71M | --384.59K |
| Administration expense | -13.05%42.34M | -25.05%22.7M | -18.72%17.5M | -20.71%9.34M | 70.22%48.7M | 95.13%30.29M | 60.36%21.53M | 74.83%11.78M | -28.90%28.61M | -62.09%15.52M |
| Financial expense | 33.30%25.59M | 99.54%20.47M | 142.41%12.78M | 44.93%5.39M | 61.00%19.2M | 32.26%10.26M | -14.49%5.27M | -6.61%3.72M | 8.06%11.92M | 68.04%7.76M |
| -Interest expense (Financial expense) | 21.86%26.84M | 53.77%20.61M | 67.25%14.01M | 68.23%6.34M | 38.78%22.02M | 13.36%13.4M | 3.33%8.38M | -4.34%3.77M | 54.23%15.87M | 175.33%11.82M |
| -Interest Income (Financial expense) | 83.20%-320.89K | 88.95%-178.25K | 88.17%-154.43K | 85.17%-82.72K | -128.63%-1.91M | -170.42%-1.61M | -670.54%-1.31M | -5,510.95%-557.91K | -754.14%-835.36K | -1,126.56%-596.65K |
| Research and development | 362.89%3.83M | 644.16%3.4M | --1.45M | --352.97K | --827.84K | 633.69%456.29K | ---- | ---- | ---- | --62.19K |
| Credit Impairment Loss | 713.01%79.94M | 197.97%6.81M | 142.53%5.3M | -158.49%-857.39K | 82.23%-13.04M | 58.98%-6.95M | 18.80%-12.47M | 3,367.54%1.47M | -86.98%-73.39M | -127.82%-16.94M |
| Asset Impairment Loss | -114,858.79%-237.33M | ---30.66M | --885.01 | ---- | 87.57%-206.44K | ---- | ---- | ---- | 91.12%-1.66M | ---- |
| Other net revenue | -621.27%-153.22M | -232.81%-20.05M | 161.96%7.45M | -49.81%786.22K | 140.43%29.39M | 61.66%-6.02M | 20.16%-12.03M | 1,091.41%1.57M | -27.23%-72.7M | -119.22%-15.71M |
| Invest income | ---- | ---- | ---- | ---- | ---- | -1,168.42%-2.53K | 4,385.66%8.56K | ---- | ---199.77 | ---199.77 |
| Asset deal income | -98.17%740.95K | 99.16%740.06K | 218.60%783.78K | --783.78K | 18,130.20%40.57M | -2.47%371.59K | 654.18%246.01K | ---- | -2.05%222.53K | --381K |
| Other revenue | 65.38%3.43M | 450.44%3.06M | 624.30%1.36M | 753.66%859.83K | -2.46%2.07M | -34.35%555.44K | -27.68%188.42K | 12.90%100.72K | 263.70%2.12M | 215.75%846.06K |
| Operating profit | -351.51%-222.88M | -176.96%-33.72M | -67.02%12.59M | -62.64%6.34M | 179.57%88.62M | 276.76%43.81M | 237.30%38.16M | 438.11%16.97M | 131.15%31.7M | 54.50%-24.78M |
| Add:Non operating Income | -98.43%332.3K | -14.83%232.53K | -66.96%65.27K | -10.12%57.4K | 1,775.90%21.16M | -72.64%273.01K | -79.71%197.54K | 188.84%63.86K | 158.67%1.13M | 737.91%997.99K |
| Less:Non operating expense | 2,338.50%10.09M | 2,466.82%9.28M | -76.74%27.57K | 201.38%12.02K | -71.46%413.67K | -53.10%361.47K | -65.69%118.5K | --3.99K | -73.89%1.45M | 47.12%770.73K |
| Total profit | -312.71%-232.64M | -197.80%-42.76M | -66.99%12.62M | -62.51%6.38M | 248.57%109.37M | 278.04%43.72M | 240.77%38.24M | 440.80%17.03M | 129.36%31.38M | 55.25%-24.56M |
| Less:Income tax cost | 20.39%263.8K | -72.61%152.42K | 1,014.93%299.41K | 19.45%203.56K | -95.86%219.13K | 406,648.36%556.47K | 19,529.29%26.85K | --170.41K | 997,964.45%5.29M | -74.64%136.81 |
| Net profit | -313.38%-232.9M | -199.42%-42.91M | -67.75%12.32M | -63.34%6.18M | 318.44%109.15M | 275.77%43.17M | 240.67%38.21M | 437.39%16.85M | 124.41%26.08M | 55.25%-24.56M |
| Net profit from continuing operation | -313.38%-232.9M | -199.42%-42.91M | -67.75%12.32M | -63.34%6.18M | 318.44%109.15M | 275.77%43.17M | 240.67%38.21M | 437.39%16.85M | 124.41%26.08M | 55.25%-24.56M |
| Less:Minority Profit | -333.62%-2.12M | 311.20%630.78K | 323.76%522.42K | 811.21%197.06K | 125,015.45%909.6K | 6,864.60%153.4K | 2,406.74%123.28K | -213.09%-27.71K | 98.78%-728.17 | 108.15%2.2K |
| Net profit of parent company owners | -313.21%-230.78M | -201.24%-43.54M | -69.01%11.8M | -64.56%5.98M | 314.94%108.24M | 275.13%43.01M | 240.19%38.09M | 438.55%16.88M | 124.42%26.09M | 55.22%-24.56M |
| Earning per share | ||||||||||
| Basic earning per share | -313.26%-0.2992 | -201.25%-0.0565 | -69.03%0.0153 | -64.38%0.0078 | 367.67%0.1403 | 275.47%0.0558 | 223.50%0.0494 | 436.92%0.0219 | 121.43%0.03 | 55.27%-0.0318 |
| Diluted earning per share | -313.26%-0.2992 | -201.25%-0.0565 | -69.03%0.0153 | -64.38%0.0078 | 367.67%0.1403 | 275.47%0.0558 | 223.50%0.0494 | 436.92%0.0219 | 121.43%0.03 | 55.27%-0.0318 |
| Other composite income | -18.83%-133.65K | 4.74K | -24.26K | -112.47K | ||||||
| Other composite income of parent company owners | -18.83%-133.65K | --4.74K | ---24.26K | ---- | ---112.47K | ---- | ---- | ---- | ---- | ---- |
| Add:Adjusted items effecting composite income | ---- | ---- | --24.26K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | -313.73%-233.03M | -199.41%-42.91M | -67.75%12.32M | -63.34%6.18M | 318.01%109.03M | 275.77%43.17M | 240.67%38.21M | 437.39%16.85M | 124.41%26.08M | 55.25%-24.56M |
| Total composite income of parent company owners | -313.56%-230.91M | -201.23%-43.54M | -69.01%11.8M | -64.56%5.98M | 314.51%108.13M | 275.13%43.01M | 240.19%38.09M | 438.55%16.88M | 124.42%26.09M | 55.22%-24.56M |
| Total composite income of minority owners | -333.62%-2.12M | 311.20%630.78K | 323.76%522.42K | 811.21%197.06K | 125,015.45%909.6K | 6,864.60%153.4K | 2,406.74%123.28K | -213.09%-27.71K | 98.78%-728.17 | 108.15%2.2K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | ZTE Accounting firm (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.